0001209191-20-037466.txt : 20200617
0001209191-20-037466.hdr.sgml : 20200617
20200617202644
ACCESSION NUMBER: 0001209191-20-037466
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200615
FILED AS OF DATE: 20200617
DATE AS OF CHANGE: 20200617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Crowley John F
CENTRAL INDEX KEY: 0001400973
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33497
FILM NUMBER: 20971024
MAIL ADDRESS:
STREET 1: C/O AMICUS THERAPEUTICS, INC.
STREET 2: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMICUS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001178879
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200422823
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
BUSINESS PHONE: (609) 662-2000
MAIL ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
FORMER COMPANY:
FORMER CONFORMED NAME: AMICUS THERAPEUTICS INC
DATE OF NAME CHANGE: 20020729
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-15
0
0001178879
AMICUS THERAPEUTICS, INC.
FOLD
0001400973
Crowley John F
C/O AMICUS THERAPEUTICS, INC.
1 CEDAR BROOK DRIVE
CRANBURY
NJ
08512
1
1
0
0
Chairman & CEO
Common Stock
2020-06-15
4
M
0
20000
5.13
A
920186
D
Common Stock
2020-06-15
4
S
0
20000
10.8805
D
900186
D
Common Stock
2020-06-15
4
F
0
163
11.14
D
900023
D
Common Stock
64895
I
By Trust
Stock Options (right to buy)
5.13
2020-06-15
4
M
0
20000
0.00
D
2027-01-03
Common Stock
20000
102485
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $10.60 to $11.17 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
As of June 15, 2020, 81,286 options were fully vested and exercisable and 41,199 remained unvested from this individual 2017 grant.
In addition to the reported transactions, Mr. Crowley also has approximately 1.56 million options outstanding and exercisable at various strike prices.
/s/ Christian Formica, Attorney-in-Fact
2020-06-17